SORAFENIB

sorafenib 200 mg tablet, 60

SORAFENIB (10226F)

sorafenib 200 mg tablet, 60
10226F
Body System:
Manner of administration:Oral
General Schedule
Authority Required

Restriction

Indication: Stage IV clear cell variant renal cell carcinoma (RCC)
Treatment phase: Initial treatment
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 2 Max qty units: 120 # of repeats: 2 DPMQ: $4,150.34 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Nexavar